LPL Financial’s OncoSec Medical Incorporated ONCS Stock Holding History

LPL Financial’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,404	Closed	-$44.9K	–	4758
2023 Q1	$44.9K	Buy	+17,404	New	+$34.5K	﹤0.01%	4318
2020 Q2	–	Sell	-1,116	Closed	-$31K	–	3563
2020 Q1	$31K	Sell	1,116 -68	-6%	-$2.54K	﹤0.01%	3117
2019 Q4	$47K	Buy	1,184 +343	+41%	+$15.5K	﹤0.01%	3279
2019 Q3	$36K	Buy	+841	New	+$39.5K	﹤0.01%	3228
2019 Q2	–	Sell	-100	Closed	-$12K	–	3392
2019 Q1	$12K	Buy	100 +55	+122%	+$7.51K	﹤0.01%	3166
2018 Q4	$6K	Buy	+45	New	+$11.3K	﹤0.01%	3061

LPL Financial's ONCS Position: Q2 2023 in Review

LPL Financial sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 17,404 shares — an estimated $44.9K sold.

LPL Financial first reported a position in ONCS in Q4 2018 and held it in 6 quarters. The position peaked at $47K in Q4 2019. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.

LPL Financial reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
LPL Financial sold 17,404 OncoSec Medical Incorporated shares in Q2 2023, an estimated $44.9K.
LPL Financial first reported a position in OncoSec Medical Incorporated in Q4 2018 and held it in 6 quarters.
LPL Financial's OncoSec Medical Incorporated position peaked at $47K in Q4 2019.
0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.

Based on LPL Financial's 13F filing for Q2 2023, filed 31 Jul 2023.